Victory Capital Management
STSA

Victory Capital Management’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Victory Capital Management’s Portfolio STSA Stock Details STSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,162
Closed -$46K – 3490
2020
Q1 		$46K Buy
+2,162
New +$49.1K ﹤0.01% 2819

Other funds holding STSA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Victory Capital Management's STSA Position: Q2 2020 in Review

Victory Capital Management sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2020, closing a stake of 2,162 shares — an estimated $46K sold.

Victory Capital Management first reported a position in STSA in Q1 2020 and held it in 1 quarter. The position peaked at $46K in Q1 2020. 52 funds tracked by Wall St. Rank hold STSA as of Q2 2020.

  • Victory Capital Management reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 2,162 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $46K.
  • Victory Capital Management first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Victory Capital Management's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $46K in Q1 2020.
  • 52 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.